2004, Safety and Side effects

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2004

Safety

Side effects

Novel oral chemotherapeutic holds potential for stomach cancer patients

European Pharmaceutical Review

JULY 5, 2022

There is an urgent need for more effective chemotherapy treatments with less severe toxicity and side effects. Irinotecan – also known by the brand name Campto/Camptosar ® (Pfizer Ltd.) – has proven to be an effective chemotherapy agent against several types of gastrointestinal cancer. Cancer Chemother Pharmacol.

Patients

Patients Food and Drug Administration Side effects Safety

PROTACs show promise for cancer treatment

Pharmaceutical Technology

JANUARY 25, 2023

By selectively degrading these proteins, PROTACs have the potential to effectively treat a range of diseases with potentially fewer side effects compared to traditional approaches. Syngene is setting up the predictive models and new platforms to overcome these challenges.”

Side effects

Side effects Leads Safety Manufacturing

Pharma Rep Focus

Novel oral chemotherapeutic holds potential for stomach cancer patients

PROTACs show promise for cancer treatment

Stay Connected